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Introduction
Aspergillus species (Fig. 1) are conidia-forming fungi that 
are responsible for a wide spectrum of human illnesses. 
About 19 species of Aspergillus have been documented as 
agents of human disease, but the majority of infections are 
caused by Aspergillus fumigates (Fresenius, 1850), Aspergil-
lus flavus (Link,1809), Aspergillus niger (Van Tieghem, 
1867), and Aspergillus terreus (Thom, 1918) [1, 2].
Clinical syndromes and diseases associated to Aspergil-
lus spp. can be: “cutaneous” (primary skin and burn-
wound infections, especially in neonates and children); 
“hypersensity” (allergic bronchopulmonary aspergil-
losis); “acute invasive” (pneumonia, ulcerative tracheo-
bronchitis, osteomyelitis,..);“chronic invasive” (chronic 
pneumonitis) [3-5].
The primary route of acquiring Aspergillus infections is 
by the inhalation of conidia [6].
The respiratory tract is therefore the most common 
portal of entry of Aspergillus spp. conidia [7]. Conidia 
of the most commonly involved pathogenic Aspergillus 
spp. are relatively small, with sizes ranging from 2 to 5 
μm [8, 9]. The small size of conidia permits them to de-
posit deep into the lung after inhalation and to reach the 
pulmonary alveolar spaces, where they may germinate 
to form hyphae. Humans inhale approximately 200 co-
nidia of filamentous fungi per day, 7 of which reach the 
alveoli. These conidia are phagocytosed by the alveolar 
macrophages and destroyed [10].
The outcome of infection depends more on host factors 
than on the virulence of the individual Aspergillus spe-
cies [2, 4, 11]. Therefore, host immunity plays a major 
role in determining who may be at risk of developing 
invasive aspergillosis (IA). The principal host defences 
against invasive Aspergillus infection are alveolar mac-
rophages, which target inhaled conidia, and neutrophils, 
which target the hyphal stage [12-14].
Immunocompromised patients are extremely susceptible 
to local invasion of respiratory tissues by deposited co-
nidia, resulting in invasive aspergillosis [12, 15]. Most 
cases of health care-acquired invasive aspergillosis 
present with pneumonia [8]. However, while invasive 
aspergillosis occurs typically in severely immunocom-
promised patients, cases of surgical site infection have 
been reported in immunocompetent individuals [8, 16].
Risk factors for invasive aspergillosis
The major risk factor for invasive aspergillosis is pro-
longed and severe neutropenia [17], both disease- and 
therapy-induced.
Patients at highest risk have severe immunosuppression 
resulting from both granulocytopenia and compromised 
cell-mediated immunity.
Guidelines for Preventing Health-Care associated Pneu-
moniae [18] highlights to maintain a high index of sus-
picion for health-care-associated pulmonary aspergil-
losis in severely immunocompromised patients (i.e., 
patients with severe, prolonged neutropenia [absolute 
neutrophil count < 500/ mm3 for 2 weeks or < 100/ 
mm3 for 1 week], most notably haematopoietic stem 
cell transplantation recipients and including recipients 
of solid organ transplants or patients with hematologic 
malignancies who are receiving chemotherapy, when 
they are severely neutropenic as defined previously) and 
persons receiving prolonged high-dose steroids.
In the “National Guidelines for the Prevention of Nosoco-
mial Invasive Aspergillosis during Construction/Renova-
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Fig. 1. Aspergillus sp. (Orlando P. et al. - Department of Health 
Sciences, University of Genoa, Italy).
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tion Activities” [19], at risk patients of invasive aspergil-
losis are classified in four groups: “Very high risk”, “High 
risk”, “Increased risk”, “No evidence of risk” (Tab. I).
Invasive aspergillosis incidence 
and mortality
Clinical reports show that the incidence of invasive 
aspergillosis differs greatly worldwide, at different 
treatment centers and even within the same institution, 
ranging from as low as 0% to 25% or more. Several 
factors are responsible for this variability. One crucial 
factor influencing the incidence of invasive aspergillosis 
is the degree of environmental exposure.
Invasive aspergillosis is associated with a high mortality 
rate ranging from 50% to 90% depending mostly on the 
recovery of the host immune response [20].
Mortality among leukaemia patients range from 13% to 
80% and can reach 95% in bone marrow transplant re-
cipients [21, 22]. Mortality rate can be as high as 100% 
if severe neutropenia persists.
Therefore, prevention of invasive aspergillosis is of 
major importance.
Hospital sources of Aspergillus spp.
Aspergillus spp. are ubiquitous fungi that commonly 
occur in soil, organically enriched debris, water, and 
decaying vegetation [23, 24]. They also survive in air 
and dust [24]. Air plays a crucial role in the spread of 
Aspergillus spp. in the environment and in the transmis-
sion to patients [25].
Due to their small size Aspergillus conidia may remain 
airborne for prolonged periods. As conidia gradually 
settle out, anything in contact with air will become con-
taminated with conidia. When an environmental reser-
voir (soil, dust, …) is disturbed, fungal conidia may be 
released into the air again. The process of settling out 
and becoming airborne again can repeat itself for pro-
longed periods of time [25].
The reduction in the concentration of airborne conidia 
is paralleled by a decrease in the frequency of invasive 
infections, but does not reduce it to zero. Although inha-
lation of airborne conidia is believed to be the primary 
route of acquiring Aspergillus infections, alternative 
modes of transmission may be present.
Recently, attention has been drawn to the role of hospi-
tal water as a possible source of filamentous fungi [26].
Warris et al. have revealed that 94% of water samples 
taken inside the examined hospital harboured filamen-
tous fungi. 
A. fumigatus was recovered from 49% of water samples 
taken from the taps in the paediatric bone marrow trans-
plantation unit of this hospital [27].
The forming of bio-films in water distribution systems 
might be responsible for sudden increases in the con-
tamination level of hospital water. So hospital water 
distribution systems may be a potential indoor reser-
voir of Aspergillus species and other molds, leading to 
Tab. I. Classification of at-risk patients.
Risk level At-risk patients
Very high risk 1. Allogeneic and autologous bone marrow transplantation
3. Peripheral stem cell transplantation
4. Non-myeloablative transplantation
5. Children with severe combined immuno-deficiency syndrome
6. Prolonged neutropenia for greater than 14 days following chemotherapy or immunosuppressive 
    therapy
7. Aplastic anaemia patients
High risk 1. Neutropenia for less than 14 days following chemotherapy
2. Adult acute lymphoblastic leukaemia on high dose steroid therapy
3. Solid organ transplantation
4. Chronic Granulomatous Disease of Childhood
5. Neonates in intensive care units
Increased risk 1. Patients on prolonged courses of high dose steroids particularly those hospitalised for prolonged 
    periods
2. Severely immunosuppressed AIDS patients
3. Patients undergoing mechanical ventilation
4. Patients having chemotherapy who are not neutropenic
5. Dialysis patients
No evidence of risk All patients not listed in previous Groups 
From the “National Guidelines for the Prevention of Nosocomial Invasive Aspergillosis During Construction/Renovation Activities”. National Disease 
Surveillance Centre (2002).
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aerosolization of fungal conidia and potential patient 
exposure.
Other sources of Aspergillus spp. in hospital environ-
ment are various foodstuffs including biscuits, tea, herbs 
and spices, shellfish, and fruit [25].
However, airborne transmission is the principal route 
of transmission of Aspergillus spp. within the hospital 
environment. To date, the minimal airborne concentra-
tion of Aspergillus conidia necessary to cause infection 
in patients with significant immunodeficiency remains 
unknown. Even concentrations of airborne Aspergillus 
conidia below 1 colony-forming unit (cfu)/m3 have been 
shown to be sufficient to cause outbreaks in immuno-
compromised patients. Rhame [28] reported a higher 
risk of invasive aspergillosis when the average density 
of A. fumigatus was 0,9 cfu/m3.
The concentration of airborne fungi in patient care areas 
during outbreak investigations ranged from 0 to more 
than 100 conidia/m3. In rooms with high-efficiency par-
ticulate air (HEPA) filtration counts below 0.1 CFU/m3 
have been reported.
Due to the prevalence of Aspergillus spp. in the hospi-
tal environment, many clinicians believe that invasive 
aspergillosis is hospital-acquired but this is not often 
proved definitively.
Patterson et al. [29] propose that an invasive aspergillo-
sis episode should be considered nosocomially-acquired 
if the clinical syndrome begins after the first week of 
hospital admission or within 14 days of hospital dis-
charge with no evidence of pre-existing or incubating 
infection on admission. Invasive aspergillosis is consid-
ered community-acquired when the clinical syndrome 
was present on admission to hospital, occurred within 
the first week of hospital admission, or occurred more 
than 14 days after hospital discharge.
Proof of the health care-acquired origin of an infection 
can only be established definitively by demonstrating 
the identity of strains isolated from the environment and 
from infected patients. 
It might be supposed that tracing the sources of As-
pergillus infections has become less difficult with the 
advent of reliable molecular typing methods, which 
are designed to determine the relatedness of particular 
subspecific strains. Often, however, it is not possible to 
demonstrate a correlation between patient and environ-
mental isolates and, on the rare occasions that some pa-
tient and environmental isolates have been shown to be 
identical, not all of the patient isolates could be matched 
with those from the environment. In most of these stud-
ies, isolates of Aspergillus from some of the patients 
with invasive aspergillosis were found to be similar to 
environmental hospital isolates, but these strains were 
not compared with isolates recovered from the patients’ 
home environments [30].
The demonstration of a relationship between invasive 
aspergillosis and airborne strains of Aspergillus is dif-
ficult because of the limited practice of environmental 
sampling for Aspergillus and for the difficulties in es-
tablishing the molecular identity of different strains. On 
the other hand, environmental investigation starts some 
time after an increased incidence of health care-acquired 
aspergillosis is recognized, but the concentration of en-
vironmental airborne fungal conidia varies constantly, 
so a hospital-acquired Aspergillus infection cannot be 
excluded even if the infecting strain is not found in the 
hospital environment.
Causes of invasive aspergillosis 
outbreaks 
Many Authors have described outbreaks of health care-
acquired invasive aspergillosis reported in intensive 
care units, transplantation units, renal unit, haematology 
and oncology units and medical wards where immuno-
suppressed patients were housed [19].
The presence of Aspergillus spp. in the health-care facil-
ity environment is a substantial extrinsic risk factor for 
opportunistic invasive aspergillosis outbreaks [5].
Some of these outbreaks have become a complication 
of construction, demolition or renovation works in or 
near hospital wards. Any patients exposed to health care 
facility construction activities or soil excavation may 
be at increased risk of acquiring a construction-related 
nosocomial infection. A study found that hospitaliza-
tion during construction was an independent risk factor 
for development of invasive nosocomial fungal infec-
tion (p = 0.09). Similarly, some Authors reported an 
increased incidence of aspergillosis over 20 years that 
coincided with the increasing number of internal hospi-
tal renovation projects and, to a lesser extent, external 
construction projects [20, 24, 25].
Site renovation and construction can disturb Aspergil-
lus-contaminated dust and produce bursts of airborne 
fungal conidia [19, 31].
Other outbreaks of health care-acquired invasive as-
pergillosis have been associated with malfunctioning 
or contamination of hospital ventilation or air filtration 
systems. 
Heating, ventilation, and air conditioning (HVAC) sys-
tems in health-care facilities allow to:
• maintain the indoor air temperature and humidity at 
comfortable levels for patients, staff, and visitors;
• remove contaminated air to protect susceptible patients 
from airborne health-care-associated pathogens. 
Malfunction of healthcare facility HVAC systems, im-
proper installation, filter inefficiencies, and poor main-
tenance can contribute to the spread of health-care–as-
sociated airborne infections [5].
Several studies have identified the type of air filter, air 
changes per hour in room, direction of airflow and air 
pressure, humidity, and ventilation-system cleaning and 
maintenance as factors related to air quality and infec-
tion rates. Microorganisms proliferate in environments 
wherever air, dust, and water are present, and air-han-
dling systems can be ideal environments for microbial 
growth. Accumulation of dust and moisture within the 
HVAC systems increase the risk for the spread of envi-
ronmental fungi and bacteria [32].
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Lutz et al. [8] describe an outbreak of Aspergillus 
infection at a tertiary care hospital among surgical 
patients associated with a contaminated air-handling 
system. This outbreak was due to insulation in vari-
able airflow volume units that had deteriorated after 
becoming wet. These units were located downstream 
of final filters, and, therefore, conidia released from 
mould growing on insulation were not filtered out 
before entering the operating theatre. No additional 
invasive Aspergillus wound infections were identified 
after the operating theatre air-handling systems were 
remediated, suggesting that this outbreak was due to 
the deterioration of insulating material in variable air-
flow volume units.
Furthermore, a failure or malfunction of the HVAC 
system may expose patients to airborne contaminants. 
Clusters of infections caused by Aspergillus spp. have 
been linked to poorly maintained and/or malfunctioning 
air conditioning systems [5]. HVAC systems require 
routine maintenance and monitoring to provide accept-
able indoor air quality efficiently and to minimize the 
risk of transmission of airborne pathogens.
Infection control measures
Prevention of invasive aspergillosis is particularly im-
portant because of the high mortality rate for at risk 
patients as patients with prolonged and severe neutro-
penia. There is no real consensus worldwide as to how 
this should be done; nevertheless, high-efficiency par-
ticulate air (HEPA) filtration of incoming air, directed 
room airflow with high frequency air changes (≥ 12/h), 
and a well-sealed room together with positive air pres-
sure in the patient’s room in relation to the corridor 
are uniformly accepted control measures to lower the 
conidia air count [20].
Outbreaks of invasive aspergillosis reinforce the im-
portance of maintaining an environment as free as 
possible of Aspergillus spp. conidia for patients who 
have severe granulocytopenia. To achieve this goal, 
specialized services in many large hospitals (particu-
larly bone-marrow transplant services) have installed 
“protected environments” for the care of their high-risk, 
severely granulocytopenic patients and have increased 
their vigilance during hospital construction and routine 
maintenance of hospital air- filtration and ventilation 
systems to prevent exposing high-risk patients to bursts 
of fungal conidia [21]. 
Providing clean filtered air and effectively controlling 
indoor air pollution through ventilation are two key 
aspects of maintaining good air quality in hospital en-
vironments [32]. The use of air filtration systems and 
other preventive measures limits drastically the access 
of outdoor fungi, reducing its concentrations.
Guidelines for Environmental Infection Control in 
Health-Care Facilities [5] show that filtration system 
with HEPA filters is adequate for most patient-care areas 
in ambulatory-care facilities and hospitals, including the 
operating room environment and areas providing central 
services. HEPA filters are at least 99.97% efficient for 
removing particles > 0.3 μm in diameter [33]. 
Several studies that have employed high efficiency par-
ticulate air (HEPA) filters in the rooms of at risk patients 
have noted significant declines in both airborne levels of 
Aspergillus and in aspergillosis infection rates [34].
Perdelli et al. [35] show that the use of air-conditioning 
systems equipped with HEPA filters markedly reduces 
the concentration of aspergilli in the environment. In 
this study, air samples were taken in 3 hospital wards 
with different air-conditioning features: no conditioning 
system (ward A), a conditioning system equipped with 
minimum efficiency reporting value (MERV) filters 
(ward B), and a conditioning system thoroughly main-
tained and equipped with high-efficiency particulate air 
(HEPA) filters (absolute) (ward C). Active sampling 
showed positive samples for fungi in wards A and B 
only, with average values of 0.50 colony-forming units 
(CFU)/m3 in A and 0.16 CFU/m3 in B. Passive sampling 
(sedimenting mycotic load) was positive only in ward A 
(mean, 0.14 CFU/cm2/h).
Hahn et al. [36] demonstrate that in the setting of an 
outbreak of aspergillosis, HEPA filters are protective 
for highly immunocompromised patients with haema-
tologic malignancies and are effective at controlling 
outbreaks due to air contamination with Aspergillus 
conidia. Particularly, an outbreak of 10 cases of health 
care-acquired invasive infection with Aspergillus flavus 
occurred among haematologic oncology patients with 
prolonged granulocytopenia housed in an environment 
with neither HEPA filters nor laminar air flow units. 
After high-efficiency particulate air (HEPA) filters 
were installed as an infection control measure, there 
were only two additional cases of health care-acquired 
aspergillosis in the 2 years following the outbreak.
Outbreaks of health care-acquired invasive aspergillosis 
during the last two decades have been reported during 
hospital construction and indoor building renovation 
and were in correlation with increased air counts of As-
pergillus organisms.
Oren et al. [37] show a health care-acquired outbreak 
of invasive pulmonary aspergillosis during extensive 
hospital construction and indoor renovation (period 1) 
in acute leukaemia patients treated in a regular ward 
that has only natural ventilation. The observed infec-
tion rate was 50%. Chemoprophylaxis with intravenous 
continuous low-dose amphotericin B was then instituted 
as a preventive measure. During the next 18 months 
(period 2) invasive pulmonary aspergillosis developed 
in 43% of acute leukaemia patients. After that period a 
new haematology ward was opened with an air filtra-
tion system through HEPA filters and none of the acute 
leukaemia or bone marrow transplantation patients who 
were hospitalized in the haematology ward developed 
invasive pulmonary aspergillosis during the following 
three years (period 3). Estimation of the number of As-
pergillus was made by air sampling in different areas in 
different periods. During period 1 and 2 they found an 
average of 15 conidia/m3, while during period 3, in the 
new haematological ward with the HEPA ventilation, 
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there was an average count of 0.18 CFU/m3 in the air, 
while counts in regular wards remained as before.
Kruger et al. [38] show that fungal air contamination in 
HEPA-conditioned patient rooms was constantly low, 
independent from construction activity.
Nevertheless, other authors have suggested that HEPA 
filtration supplies alone are not sufficient to prevent 
health care-acquired aspergillosis, because outbreaks of 
invasive aspergillosis have been described in units with 
HEPA filtration.
A study of Cornet et al. [22] has shown that although 
HEPA filtration significantly reduced the air counts for 
Aspergillus during periods when no construction was 
taking place, only HEPA filtration plus laminar airflow 
(LAF) had a significant impact during periods of con-
struction.
When LAF is provided, the air is usually swept across 
the room parallel to the floor driving contaminants 
out through the ducts. Nevertheless, laminar airflow 
usually involves 400 air changes per hour or more 
and is expensive, uncomfortable due to draughts and 
noise [39].
In conclusion, it is practically impossible to eliminate 
the risk of aspergillosis entirely, but it can be reduced to 
a minimum. Indeed, the use of an appropriate air-condi-
tioning system (equipped with HEPA absolute filters), 
proper maintenance of the system itself, the application 
of protocols for sanitization and staff behaviour recom-
mended for critical wards, such as compliance with 
procedural norms (eg, avoid frequent opening of doors 
between the patient care areas and the outer environ-
ment) etc., contribute to reducing the risk of aspergil-
losis significantly.
Moreover, monitoring and evaluation of fungal conidia 
counts in healthcare settings is recommended to assess 
the efficiency of the air filtration process and a consen-
sus on the tolerable breakpoint concentration of airborne 
fungi is needed [40].
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